e-learning
resources
Munich 2006
Sunday 03.09.2006
Clinical management of interstitial lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antidepressants overdose-induced lung disease
N. Mogulkoc, D. Atasever, R. Savas, A. Veral (Izmir, Turkey)
Source:
Annual Congress 2006 - Clinical management of interstitial lung disease
Session:
Clinical management of interstitial lung disease
Session type:
E-Posters in free access
Number:
656
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Mogulkoc, D. Atasever, R. Savas, A. Veral (Izmir, Turkey). Antidepressants overdose-induced lung disease. Eur Respir J 2006; 28: Suppl. 50, 656
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Mild parenchymal lung disease is still lung disease
Source: Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020
Year: 2020
Mild parenchymal lung disease is still lung disease
Source: Eur Respir J, 56 (5) 2003542; 10.1183/13993003.03542-2020
Year: 2020
Senotherapies for chronic lung disease
Source: ERS Lung Science Conference 2020
Year: 2020
Tele-rehabilitation in chronic lung diseases
Source: ERS Course 2017
Year: 2017
Siphonage lung disease
Source: Virtual Congress 2020 – Respiratory critical care
Year: 2020
Mechanisms of lung disease in AATD
Source: Eur Respir Monogr 2019; 85: 52-63
Year: 2019
Smoking-induced lung disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=134
Year: 2007
Statin-induced lung diseases
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Comorbidities in interstitial lung diseases
Source: Eur Respir Rev 2017; 26: 160027
Year: 2017
Mitochondrial dysfunction in chronic lung disease
Source: International Congress 2016 – Dysfunctional mitochondria in respiratory disease
Year: 2016
Frailty in chronic lung disorders
Source: Virtual Congress 2020 – Managing frailty in patients with acute or chronic lung disorders
Year: 2020
Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2016
Year: 2016
Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017
Mechanisms of liver disease in AATD
Source: Eur Respir Monogr 2019; 85: 93-104
Year: 2019
Biomarkers for interstitial lung disease
Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease
Year: 2016
Inhalational lung diseases
Source: Annual Congress 2012 - Imaging Grand Round: an interactive session
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept